Craig C. Hopkinson - Feb 22, 2024 Form 4 Insider Report for Alkermes plc. (ALKS)

Role: EVP R&D, Chief Medical Officer
Signature: /s/ Jeffrey Geary, attorney-in-fact for Craig C. Hopkinson
Stock symbol: ALKS
Transactions as of: Feb 22, 2024
Transactions value $: -$157,617
Form type: 4
Date filed: 2/23/2024, 04:07 PM
Previous filing: Feb 21, 2024
Next filing: Feb 27, 2024
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ALKS	Ordinary Shares	Options Exercise		+12.3K	+12.45%		111K	Feb 22, 2024	Direct	F1
transaction	ALKS	Ordinary Shares	Tax liability	-$158K	-5.45K	-4.92%	$28.91	105K	Feb 22, 2024	Direct

Showing 1 to 2 of 2 entries

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	ALKS	Restricted Stock Unit Award	Options Exercise		-12.3K	-50%		12.3K	Feb 22, 2024	Ordinary Shares	12.3K		Direct	F1, F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Each restricted stock unit represents a contingent right to receive one ordinary share.
F2	Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 2/22/2022.